The Board of Directors of Hyundai Pharmaceutical Co., Ltd. has authorized a buyback plan on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,800 KRW | -0.26% | +1.33% | -7.54% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-7.54% | 76.41M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.